Bellicum Pharmaceuticals Inc (BLCM) formed multiple bottom with $12.30 target or 3.00 % below today’s $12.68 share price. Bellicum Pharmaceuticals Inc (BLCM) has $436.98M valuation. The stock increased 4.11% or $0.5 on May 12, reaching $12.68. About shares traded. Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has declined 37.51% since October 6, 2016 and is downtrending. It has underperformed by 48.16% the S&P500.
Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Ratings Coverage
Among 9 analysts covering Bellicum Pharmaceuticals Inc (NASDAQ:BLCM), 7 have Buy rating, 1 Sell and 1 Hold. Therefore 78% are positive. Bellicum Pharmaceuticals Inc has $32 highest and $22 lowest target. $27.25’s average target is 114.91% above currents $12.68 stock price. Bellicum Pharmaceuticals Inc had 12 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was initiated by Raymond James with “Outperform” on Thursday, December 1. The stock has “Buy” rating by Suntrust Robinson on Friday, June 3. The stock has “Buy” rating by Cantor Fitzgerald on Wednesday, November 2. The stock has “Neutral” rating by Citigroup on Tuesday, August 9. The stock of Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has “Hold” rating given on Wednesday, August 19 by Zacks. The firm has “Buy” rating by SunTrust given on Friday, June 3. The firm has “Neutral” rating by Citigroup given on Thursday, February 25. On Monday, September 21 the stock rating was downgraded by Zacks to “Sell”. The stock of Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) earned “Buy” rating by Guggenheim on Friday, September 11. Jefferies maintained it with “Buy” rating and $22 target in Tuesday, August 9 report.
The post Bellicum Pharmaceuticals Inc (BLCM) At $12.68 Forms Bottom appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2017/05/15/bellicum-pharmaceuticals-inc-blcm-at-12-68-forms-bottom/
No comments:
Post a Comment